MIRAQULES
Biomedical startup developing biomaterial-based, fast-acting hemostatic compounds and point-of-care wound management products. The organization designs fibrous, high-absorbency biomaterials intended to accelerate clot formation and has advanced its lead products through preclinical studies, pilot manufacturing and regulatory interactions.
Industries
Nr. of Employees
small (1-50)
Products
StopBleed Powder
High-absorbency hemostatic powder formulated for irregular and complex wounds to accelerate clotting and reduce bleeding; intended for point-of-care use by untrained users.
StopBleed Pro (pellet + applicator)
Pre-filled pellet delivered via single-use applicator designed for targeted delivery into narrow-entry wounds (e.g., gunshot or stabbing wounds) to provide focused hemostasis.
Stop Bleed
Ideal for targeted & precise delivery. The applicator and individual pallets are designed for narrow entry wounds.
Stop Bleed Powder
Ideal for irregular and complex wounds. Stops the bleeding 5x faster than other similar products in the market.
StopBleed Pro
An advanced hemostatic applicator and pellet system designed for narrow entry wounds, providing rapid bleeding control in emergency situations without generating heat.
InstaBrin
A proprietary biomaterial-based wound healing product developed by Miraqules.
StopBleed Powder
High-absorbency hemostatic powder formulated for irregular and complex wounds to accelerate clotting and reduce bleeding; intended for point-of-care use by untrained users.
StopBleed Pro (pellet + applicator)
Pre-filled pellet delivered via single-use applicator designed for targeted delivery into narrow-entry wounds (e.g., gunshot or stabbing wounds) to provide focused hemostasis.
Stop Bleed
Ideal for targeted & precise delivery. The applicator and individual pallets are designed for narrow entry wounds.
Stop Bleed Powder
Ideal for irregular and complex wounds. Stops the bleeding 5x faster than other similar products in the market.
StopBleed Pro
An advanced hemostatic applicator and pellet system designed for narrow entry wounds, providing rapid bleeding control in emergency situations without generating heat.
InstaBrin
A proprietary biomaterial-based wound healing product developed by Miraqules.
Expertise Areas
- Biomaterial-based hemostat development
- Wound management product development
- Preclinical and large-animal study execution
- Pilot-scale manufacturing and process scale-up
Key Technologies
- Fibrous biomaterial fabrication (room-temperature, electrospinning alternative)
- High-absorbency fibrous matrices
- Polysaccharide-based hemostatic formulations
- Preclinical animal models (mice, rabbits, pigs)
News & Updates
Pilot-scale manufacturing completed; ISO 13485 certification obtained (Q3 2024) and CDSCO manufacturing license expected (Q4 2024).
Pre-seed investment of approximately INR 3 Crores (~$400K) raised in 2021.
US FDA pre-submission interactions (Q1 2021), submission of Q-Sub, large-animal safety and efficacy studies completed (2023), IEC approval obtained from a medical college (Q4 2023).
Multiple grants and recognitions including government grants, accelerator finalist placements and international startup rankings from 2018 onward.
Pilot-scale manufacturing completed; ISO 13485 certification obtained (Q3 2024) and CDSCO manufacturing license expected (Q4 2024).
Pre-seed investment of approximately INR 3 Crores (~$400K) raised in 2021.
US FDA pre-submission interactions (Q1 2021), submission of Q-Sub, large-animal safety and efficacy studies completed (2023), IEC approval obtained from a medical college (Q4 2023).
Multiple grants and recognitions including government grants, accelerator finalist placements and international startup rankings from 2018 onward.